Navigation Links
DrugRisks News Update: Bayer Loses Yaz Patent as Blood Clot Settlements Continue
Date:4/26/2013

Chicago, IL (PRWEB) April 26, 2013

The birth control safety advocates at DrugRisks.com have added new information to the site for women using the contraceptives Yaz or Yasmin. A court recently ordered that Bayer no longer holds a patent on the drugs as the company continues to settle claims from patients alleging blood clot injuries**.

DrugRisks was created to give patients taking popular prescription drugs like Yaz and Yasmin the latest warnings, recalls, studies and legal news. With access to clear information, patients can discuss side effect concerns with their doctor and decide if they need legal advice.

The British Medical Journal and FDA have cautioned that birth control pills containing drospirenone, like Yaz and Yasmin, can increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%*.

With a growing number of patients filing a Yaz lawsuit alleging blood clot injuries, cases were consolidated to a special federal Multi-District Litigation court in Illinois (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).

Now, DrugRisks has added information showing the U.S. Circuit Court of Appeals for Washington last week ruled Bayer’s patent on Yaz, which was set to expire in 2014, is no longer valid**. This will allows competitors Actavis, Sandoz and Lupin to continue selling their generic versions of the drug**.

Bayer’s latest financial reports show the company has spent nearly $1 billion to settle around 4,800 claims alleging Yaz blood clots, and will continue to evaluate new claims for settlement on a case-by-case basis***.

Lawyers are still helping those affected file a claim. Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is urged to contact the DrugRisks Center or speak with a lawyer about their legal options.

Due to the specialized nature of federal MDL drug injury cases, DrugRisks cautions that patients should seek a lawyer with experience in this litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

Visit http://www.DrugRisks.com today for more information on the research, Yaz side effects and litigation news related to Yaz or Yasmin, or to speak with a lawyer.

*British Medical Journal, October 25, 2011, University of Copenhagen; FDA, October 27, 2011, "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints"
**businessweek.com/news/2013-04-16/bayer-patent-on-yaz-birth-control-pill-ruled-invalid
***Bayer 2012 Annual Report, Consolidated Financial Statement, Legal Notes, February 28, 2013

Read the full story at http://www.prweb.com/releases/yaz-side-effects/2013-settlement-news/prweb10662368.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisks Adds Update From Court Ordering Mediation of Stryker Hip Lawsuits
2. DrugRisks Update: Federal Court Schedules First Mirena Lawsuit Hearing
3. DrugRisks Legal Update: Jury to Decide Actos Cancer Trial This Week
4. DrugRisks Update: Doctor Testifies Actos Main Cause of Bladder Cancer in Trial
5. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
6. DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court
7. DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
8. DrugRisks Adds New Pradaxa Study Alert As Lawsuits Increase
9. DrugRisks Adds Update from First Actos Trial of Patient Alleging Bladder Cancer
10. Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Some CasesDismissed from Consolidated Litigation
11. DrugRisk Update: Court Asks for Pradaxa Lawsuit Test Cases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology: